Abstract
PB0924 Venous Thromboembolism Risk in Lung Cancer Patients Receiving First-Line Immune Checkpoint Inhibitor Versus Chemotherapy
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have